Citric Acid Market Giants Spending Is Going To Boom with Cargill, Tate Lyle, Cofco Biochemical - openPR
| 000930 Stock | 5.78 0.04 0.69% |
About 62% of Cofco Biochemical's investor base is looking to short. The analysis of overall sentiment of trading Cofco Biochemical Anhui stock suggests that many investors are alarmed at this time. The current market sentiment, together with Cofco Biochemical's historical and current headlines, can help investors time the market. In addition, many technical investors use Cofco Biochemical Anhui stock news signals to limit their universe of possible portfolio assets.
Cofco |
Citric Acid Market Giants Spending Is Going To Boom with Cargill, Tate Lyle, Cofco Biochemical openPR
Read at news.google.com
 |
Cofco Biochemical Fundamental Analysis
We analyze Cofco Biochemical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cofco Biochemical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cofco Biochemical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Cofco Biochemical is currently under evaluation in net asset category among its peers. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Cofco Biochemical Anhui Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cofco Biochemical stock to make a market-neutral strategy. Peer analysis of Cofco Biochemical could also be used in its relative valuation, which is a method of valuing Cofco Biochemical by comparing valuation metrics with similar companies.
Peers
Cofco Biochemical Related Equities
| 603559 | Zhongtong Guomai | 4.99 | ||||
| 600804 | Dr Peng | 3.11 | ||||
| 600345 | Wuhan Yangtze | 1.89 | ||||
| 600831 | Shaanxi Broadcast | 1.72 | ||||
| 002861 | Hubei Yingtong | 1.69 | ||||
| 600498 | Fiberhome Telecommunicatio | 1.71 | ||||
| 603860 | RoadMain T | 2.11 |
Complementary Tools for Cofco Stock analysis
When running Cofco Biochemical's price analysis, check to measure Cofco Biochemical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cofco Biochemical is operating at the current time. Most of Cofco Biochemical's value examination focuses on studying past and present price action to predict the probability of Cofco Biochemical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cofco Biochemical's price. Additionally, you may evaluate how the addition of Cofco Biochemical to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |